We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy.

list of NY corporations

Alzheimer’s Drug Is Bonanza for Biogen, Most Likely at Taxpayer Expense


Despite scant evidence that it works, the drug, Aduhelm, is predicted to generate billions of dollars in revenue, much of it from Medicare.
read more

Source: NY Times


20:27, June 8, 2021 Rebecca Robbins and Pam Belluck

You may also like

News